{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:53:26Z","timestamp":1790636006313,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The importance of natural IgM antibodies in protection against infections is still emerging and these antibodies have a potential role in the maintenance of homeostasis through clearance of apoptotic bodies, complement-dependent mechanisms, inflammation and exclusion of misfolded proteins. Natural IgM act as a first line of defence against unknown hazardous factors and are present in most vertebrates. We investigated the functional capacity of anti-HIV-1 IgM monoclonal antibodies, from a combinatorial Fab library derived from healthy individuals, and evaluated their protective role in inhibiting HIV-1<jats:italic>in vitro<\/jats:italic>when passing across the human mucosal epithelial barrier. Primary HIV-1 isolates were efficiently transmitted over the tight polarized epithelial cells when added to their apical surface. Efficient inhibition of HIV-1 transmission was achieved when anti-HIV-1 IgM monoclonal antibodies were added to the basolateral side of the cells. Two of these human IgM MoAbs had the ability to neutralize HIV and reduced infection of dendritic cells in primary cervico-vaginal tissue biopsies<jats:italic>in vitro<\/jats:italic>. This indicates a potential role of natural IgM antibodies in the reduction of HIV-1 transmission in mucosal tissues and improve our understanding of how natural IgM antibodies against a neutralizing epitope could interfere with viral transmission.<\/jats:p>","DOI":"10.1038\/s41598-018-28242-y","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T10:52:17Z","timestamp":1530269537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Human IgM monoclonal antibodies block HIV-transmission to immune cells in cervico-vaginal tissues and across polarized epithelial cells in vitro"],"prefix":"10.1038","volume":"8","author":[{"given":"Claudia","family":"Devito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rada","family":"Elleg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Falkeborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Ohlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Broliden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorma","family":"Hinkula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,5]]},"reference":[{"key":"28242_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fimmu.2012.00066","volume":"3","author":"C Gronwall","year":"2012","unstructured":"Gronwall, C., Vas, J. & Silverman, G. J. Protective Roles of Natural IgM Antibodies. Front Immunol 3, 66, https:\/\/doi.org\/10.3389\/fimmu.2012.00066 (2012).","journal-title":"Front Immunol"},{"key":"28242_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ncprheum0895","volume":"4","author":"K Elkon","year":"2008","unstructured":"Elkon, K. & Casali, P. Nature and functions of autoantibodies. Nat Clin Pract Rheumatol 4, 491\u2013498, https:\/\/doi.org\/10.1038\/ncprheum0895 (2008).","journal-title":"Nat Clin Pract Rheumatol"},{"key":"28242_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1743-422X-9-26","volume":"9","author":"F Gao","year":"2012","unstructured":"Gao, F. et al. Enterovirus 71 viral capsid protein linear epitopes: identification and characterization. Virol J 9, 26, https:\/\/doi.org\/10.1186\/1743-422X-9-26 (2012).","journal-title":"Virol J"},{"key":"28242_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/jmv.1019","volume":"64","author":"E Manaresi","year":"2001","unstructured":"Manaresi, E. et al. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins. J Med Virol 64, 67\u201373 (2001).","journal-title":"J Med Virol"},{"key":"28242_CR5","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0161-5890(01)00007-4","volume":"37","author":"NM Mertens","year":"2000","unstructured":"Mertens, N. M., Galvin, J. E., Adderson, E. E. & Cunningham, M. W. Molecular analysis of cross-reactive anti-myosin\/anti-streptococcal mouse monoclonal antibodies. Mol Immunol 37, 901\u2013913 (2000).","journal-title":"Mol Immunol"},{"key":"28242_CR6","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1084\/jem.168.6.1979","volume":"168","author":"SE Burastero","year":"1988","unstructured":"Burastero, S. E., Casali, P., Wilder, R. L. & Notkins, A. L. Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis. J Exp Med 168, 1979\u20131992 (1988).","journal-title":"J Exp Med"},{"key":"28242_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1365-3083.1990.tb02929.x","volume":"32","author":"SE Burastero","year":"1990","unstructured":"Burastero, S. E., Cutolo, M., Dessi, V. & Celada, F. Monoreactive and polyreactive rheumatoid factors produced by in vitro Epstein-Barr virus-transformed peripheral blood and synovial B lymphocytes from rheumatoid arthritis patients. Scand J Immunol 32, 347\u2013357 (1990).","journal-title":"Scand J Immunol"},{"key":"28242_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1006\/clin.1995.1066","volume":"75","author":"Q Fang","year":"1995","unstructured":"Fang, Q., Kannapell, C. C., Fu, S. M., Xu, S. & Gaskin, F. VH and VL gene usage by anti-beta-amyloid autoantibodies in Alzheimer\u2019s disease: detection of highly mutated V regions in both heavy and light chains. Clin Immunol Immunopathol 75, 159\u2013167 (1995).","journal-title":"Clin Immunol Immunopathol"},{"key":"28242_CR9","unstructured":"Brandtzaeg, P. In Handbook of mucosal immunology (ed. Ogra, P. L. et al.) (Academic Press, San Diego, 1994)."},{"key":"28242_CR10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/252418a0","volume":"252","author":"P Brandtzaeg","year":"1974","unstructured":"Brandtzaeg, P. Presence of J chain in human immunocytes containing various immunoglobulin classes. Nature 252, 418\u2013420 (1974).","journal-title":"Nature"},{"key":"28242_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-3083.1978.tb00494.x","volume":"8","author":"P Brandtzaeg","year":"1978","unstructured":"Brandtzaeg, P. Polymeric IgA is complexed with secretory component (SC) on the surface of human intestinal epithelial cells. Scand J Immunol 8, 39\u201352 (1978).","journal-title":"Scand J Immunol"},{"key":"28242_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/80886","volume":"1","author":"A Shibuya","year":"2000","unstructured":"Shibuya, A. et al. Fc alpha\/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol 1, 441\u2013446, https:\/\/doi.org\/10.1038\/80886 (2000).","journal-title":"Nat Immunol"},{"issue":"Pt 1","key":"28242_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1099\/0022-1317-71-1-69","volume":"71","author":"MC Outlaw","year":"1990","unstructured":"Outlaw, M. C. & Dimmock, N. J. Mechanisms of neutralization of influenza virus on mouse tracheal epithelial cells by mouse monoclonal polymeric IgA and polyclonal IgM directed against the viral haemagglutinin. J Gen Virol 71(Pt 1), 69\u201376, https:\/\/doi.org\/10.1099\/0022-1317-71-1-69 (1990).","journal-title":"J Gen Virol"},{"key":"28242_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/smvy.1996.0034","volume":"7","author":"J Crowe","year":"1996","unstructured":"Crowe, J. The role of antibodies in respiratory viral immunity. Seminars in Virology 7, 273\u2013283 (1996).","journal-title":"Seminars in Virology"},{"key":"28242_CR15","doi-asserted-by":"publisher","first-page":"6901","DOI":"10.1073\/pnas.89.15.6901","volume":"89","author":"MB Mazanec","year":"1992","unstructured":"Mazanec, M. B., Kaetzel, C. S., Lamm, M. E., Fletcher, D. & Nedrud, J. G. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA 89, 6901\u20136905 (1992).","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 3","key":"28242_CR16","doi-asserted-by":"publisher","first-page":"S448","DOI":"10.1086\/314802","volume":"179","author":"H Hocini","year":"1999","unstructured":"Hocini, H. & Bomsel, M. Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. J Infect Dis 179(Suppl 3), S448\u2013453, https:\/\/doi.org\/10.1086\/314802 (1999).","journal-title":"J Infect Dis"},{"key":"28242_CR17","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1089\/aid.1997.13.1179","volume":"13","author":"H Hocini","year":"1997","unstructured":"Hocini, H. et al. High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160. AIDS Res Hum Retroviruses 13, 1179\u20131185, https:\/\/doi.org\/10.1089\/aid.1997.13.1179 (1997).","journal-title":"AIDS Res Hum Retroviruses"},{"key":"28242_CR18","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.4049\/jimmunol.165.9.5170","volume":"165","author":"C Devito","year":"2000","unstructured":"Devito, C. et al. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J Immunol 165, 5170\u20135176 (2000).","journal-title":"J Immunol"},{"key":"28242_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/v2020547","volume":"2","author":"W Chen","year":"2010","unstructured":"Chen, W. et al. Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins. Viruses 2, 547\u2013565, https:\/\/doi.org\/10.3390\/v2020547 (2010).","journal-title":"Viruses"},{"key":"28242_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1365-2249.1992.tb06947.x","volume":"89","author":"M Ohlin","year":"1992","unstructured":"Ohlin, M. et al. Human MoAbs produced from normal, HIV-1-negative donors and specific for glycoprotein gp120 of the HIV-1 envelope. Clin Exp Immunol 89, 290\u2013295 (1992).","journal-title":"Clin Exp Immunol"},{"key":"28242_CR21","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nature05580","volume":"445","author":"T Zhou","year":"2007","unstructured":"Zhou, T. et al. Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 445, 732\u2013737, https:\/\/doi.org\/10.1038\/nature05580 (2007).","journal-title":"Nature"},{"key":"28242_CR22","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1073\/pnas.88.8.3238","volume":"88","author":"MK Gorny","year":"1991","unstructured":"Gorny, M. K. et al. Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein. Proc Natl Acad Sci USA 88, 3238\u20133242 (1991).","journal-title":"Proc Natl Acad Sci USA"},{"key":"28242_CR23","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1128\/JVI.03104-12","volume":"87","author":"A Desormeaux","year":"2013","unstructured":"Desormeaux, A. et al. The highly conserved layer-3 component of the HIV-1 gp120 inner domain is critical for CD4-required conformational transitions. J Virol 87, 2549\u20132562, https:\/\/doi.org\/10.1128\/JVI.03104-12 (2013).","journal-title":"J Virol"},{"key":"28242_CR24","doi-asserted-by":"crossref","unstructured":"Herrera, C. et al. Nonneutralizing antibodies to the CD4-binding site on the gp120 subunit of human immunodeficiency virus type 1 do not interfere with the activity of a neutralizing antibody against the same site. J Virol 77, 1084\u20131091 (2003).","DOI":"10.1128\/JVI.77.2.1084-1091.2003"},{"key":"28242_CR25","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1146\/annurev.immunol.24.021605.090557","volume":"24","author":"R Pantophlet","year":"2006","unstructured":"Pantophlet, R. & Burton, D. R. GP120: target for neutralizing HIV-1 antibodies. Annu Rev Immunol 24, 739\u2013769, https:\/\/doi.org\/10.1146\/annurev.immunol.24.021605.090557 (2006).","journal-title":"Annu Rev Immunol"},{"key":"28242_CR26","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/infdis\/jiq175","volume":"203","author":"P Spearman","year":"2011","unstructured":"Spearman, P. et al. A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers. J Infect Dis 203, 1165\u20131173, https:\/\/doi.org\/10.1093\/infdis\/jiq175 (2011).","journal-title":"J Infect Dis"},{"key":"28242_CR27","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.4049\/jimmunol.1200981","volume":"189","author":"SA Planque","year":"2012","unstructured":"Planque, S. A. et al. Antibodies to a superantigenic glycoprotein 120 epitope as the basis for developing an HIV vaccine. J Immunol 189, 5367\u20135381, https:\/\/doi.org\/10.4049\/jimmunol.1200981 (2012).","journal-title":"J Immunol"},{"key":"28242_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0092-8674(86)90778-6","volume":"45","author":"BR Starcich","year":"1986","unstructured":"Starcich, B. R. et al. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III\/LAV, the retrovirus of AIDS. Cell 45, 637\u2013648 (1986).","journal-title":"Cell"},{"key":"28242_CR29","doi-asserted-by":"publisher","first-page":"262ra157","DOI":"10.1126\/scitranslmed.3009634","volume":"6","author":"O Zirafi","year":"2014","unstructured":"Zirafi, O. et al. Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides. Sci Transl Med 6, 262ra157, https:\/\/doi.org\/10.1126\/scitranslmed.3009634 (2014).","journal-title":"Sci Transl Med"},{"key":"28242_CR30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.rbmo.2014.11.008","volume":"30","author":"JM Fourie","year":"2015","unstructured":"Fourie, J. M., Loskutoff, N. & Huyser, C. Semen decontamination for the elimination of seminal HIV-1. Reprod Biomed Online 30, 296\u2013302, https:\/\/doi.org\/10.1016\/j.rbmo.2014.11.008 (2015).","journal-title":"Reprod Biomed Online"},{"issue":"Suppl 3","key":"28242_CR31","doi-asserted-by":"publisher","first-page":"S622","DOI":"10.1093\/infdis\/jiu328","volume":"210","author":"L Houzet","year":"2014","unstructured":"Houzet, L., Matusali, G. & Dejucq-Rainsford, N. Origins of HIV-infected leukocytes and virions in semen. J Infect Dis 210(Suppl 3), S622\u2013630, https:\/\/doi.org\/10.1093\/infdis\/jiu328 (2014).","journal-title":"J Infect Dis"},{"key":"28242_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(85)90585-9","volume":"2","author":"GJ Stewart","year":"1985","unstructured":"Stewart, G. J. et al. Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor. Lancet 2, 581\u2013585 (1985).","journal-title":"Lancet"},{"key":"28242_CR33","first-page":"13","volume":"146","author":"P Brandtzaeg","year":"1989","unstructured":"Brandtzaeg, P. Overview of the mucosal immune system. Curr Top Microbiol Immunol 146, 13\u201325 (1989).","journal-title":"Curr Top Microbiol Immunol"},{"key":"28242_CR34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1600-065X.1997.tb01009.x","volume":"159","author":"W Gerhard","year":"1997","unstructured":"Gerhard, W., Mozdzanowska, K., Furchner, M., Washko, G. & Maiese, K. Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol Rev 159, 95\u2013103 (1997).","journal-title":"Immunol Rev"},{"key":"28242_CR35","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.2672330","volume":"245","author":"E Rodriguez-Boulan","year":"1989","unstructured":"Rodriguez-Boulan, E. & Nelson, W. J. Morphogenesis of the polarized epithelial cell phenotype. Science 245, 718\u2013725 (1989).","journal-title":"Science"},{"key":"28242_CR36","doi-asserted-by":"publisher","first-page":"16969","DOI":"10.1073\/pnas.012669199","volume":"99","author":"JS Brown","year":"2002","unstructured":"Brown, J. S. et al. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci USA 99, 16969\u201316974, https:\/\/doi.org\/10.1073\/pnas.012669199 (2002).","journal-title":"Proc Natl Acad Sci USA"},{"key":"28242_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.immuni.2005.04.011","volume":"23","author":"KM Haas","year":"2005","unstructured":"Haas, K. M., Poe, J. C., Steeber, D. A. & Tedder, T. F. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23, 7\u201318, https:\/\/doi.org\/10.1016\/j.immuni.2005.04.011 (2005).","journal-title":"Immunity"},{"key":"28242_CR38","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.4049\/jimmunol.170.7.3819","volume":"170","author":"KR Alugupalli","year":"2003","unstructured":"Alugupalli, K. R. et al. The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol 170, 3819\u20133827 (2003).","journal-title":"J Immunol"},{"key":"28242_CR39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.immuni.2004.06.019","volume":"21","author":"KR Alugupalli","year":"2004","unstructured":"Alugupalli, K. R. et al. B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity 21, 379\u2013390, https:\/\/doi.org\/10.1016\/j.immuni.2004.06.019 (2004).","journal-title":"Immunity"},{"key":"28242_CR40","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1084\/jem.20080979","volume":"205","author":"YS Choi","year":"2008","unstructured":"Choi, Y. S. & Baumgarth, N. Dual role for B-1a cells in immunity to influenza virus infection. J Exp Med 205, 3053\u20133064, https:\/\/doi.org\/10.1084\/jem.20080979 (2008).","journal-title":"J Exp Med"},{"key":"28242_CR41","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jcv.2013.09.006","volume":"58","author":"M Justel","year":"2013","unstructured":"Justel, M. et al. IgM levels in plasma predict outcome in severe pandemic influenza. J Clin Virol 58, 564\u2013567, https:\/\/doi.org\/10.1016\/j.jcv.2013.09.006 (2013).","journal-title":"J Clin Virol"},{"key":"28242_CR42","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.4049\/jimmunol.1102808","volume":"188","author":"A Bortnick","year":"2012","unstructured":"Bortnick, A. et al. Long-lived bone marrow plasma cells are induced early in response to T cell-independent or T cell-dependent antigens. J Immunol 188, 5389\u20135396, https:\/\/doi.org\/10.4049\/jimmunol.1102808 (2012).","journal-title":"J Immunol"},{"key":"28242_CR43","doi-asserted-by":"publisher","first-page":"13467","DOI":"10.1128\/JVI.01896-12","volume":"86","author":"M Kajihara","year":"2012","unstructured":"Kajihara, M. et al. Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein. J Virol 86, 13467\u201313474, https:\/\/doi.org\/10.1128\/JVI.01896-12 (2012).","journal-title":"J Virol"},{"key":"28242_CR44","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1074-7613(00)80610-X","volume":"9","author":"M Bomsel","year":"1998","unstructured":"Bomsel, M. et al. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity 9, 277\u2013287 (1998).","journal-title":"Immunity"},{"key":"28242_CR45","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.4049\/jimmunol.159.9.4330","volume":"159","author":"IB Natvig","year":"1997","unstructured":"Natvig, I. B., Johansen, F. E., Nordeng, T. W., Haraldsen, G. & Brandtzaeg, P. Mechanism for enhanced external transfer of dimeric IgA over pentameric IgM: studies of diffusion, binding to the human polymeric Ig receptor, and epithelial transcytosis. J Immunol 159, 4330\u20134340 (1997).","journal-title":"J Immunol"},{"key":"28242_CR46","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/0952-7915(95)80087-5","volume":"7","author":"SL Rowland-Jones","year":"1995","unstructured":"Rowland-Jones, S. L. & McMichael, A. Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr Opin Immunol 7, 448\u2013455 (1995).","journal-title":"Curr Opin Immunol"},{"key":"28242_CR47","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/jvi.68.9.6103-6110.1994","volume":"68","author":"P Borrow","year":"1994","unstructured":"Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M. & Oldstone, M. B. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68, 6103\u20136110 (1994).","journal-title":"J Virol"},{"key":"28242_CR48","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1172\/JCI119473","volume":"99","author":"FC Fang","year":"1997","unstructured":"Fang, F. C. Perspectives series: host\/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 99, 2818\u20132825, https:\/\/doi.org\/10.1172\/JCI119473 (1997).","journal-title":"Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest"},{"key":"28242_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1034\/j.1600-065X.2000.917304.x","volume":"173","author":"G Diamond","year":"2000","unstructured":"Diamond, G., Legarda, D. & Ryan, L. K. The innate immune response of the respiratory epithelium. Immunol Rev 173, 27\u201338 (2000).","journal-title":"Immunol Rev"},{"key":"28242_CR50","unstructured":"Hansson, L. N., R. In Immunology Vol. 2 (ed. L; Wigzell Hansson, H) 245\u2013258 (Esselte, 1998)."},{"key":"28242_CR51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/gene.2014.78","volume":"16","author":"M Frankowiack","year":"2015","unstructured":"Frankowiack, M. et al. The higher frequency of IgA deficiency among Swedish twins is not explained by HLA haplotypes. Genes Immun 16, 199\u2013205, https:\/\/doi.org\/10.1038\/gene.2014.78 (2015).","journal-title":"Genes Immun"},{"key":"28242_CR52","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1084\/jem.192.2.271","volume":"192","author":"N Baumgarth","year":"2000","unstructured":"Baumgarth, N. et al. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 192, 271\u2013280 (2000).","journal-title":"J Exp Med"},{"key":"28242_CR53","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1126\/science.286.5447.2156","volume":"286","author":"AF Ochsenbein","year":"1999","unstructured":"Ochsenbein, A. F. et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286, 2156\u20132159 (1999).","journal-title":"Science"},{"key":"28242_CR54","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.4049\/jimmunol.177.7.4627","volume":"177","author":"M Kinoshita","year":"2006","unstructured":"Kinoshita, M. et al. Restoration of natural IgM production from liver B cells by exogenous IL-18 improves the survival of burn-injured mice infected with Pseudomonas aeruginosa. J Immunol 177, 4627\u20134635 (2006).","journal-title":"J Immunol"},{"key":"28242_CR55","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0140-6736(86)90884-6","volume":"1","author":"MW Vogt","year":"1986","unstructured":"Vogt, M. W. et al. Isolation of HTLV-III\/LAV from cervical secretions of women at risk for AIDS. Lancet 1, 525\u2013527 (1986).","journal-title":"Lancet"},{"key":"28242_CR56","doi-asserted-by":"publisher","first-page":"12559","DOI":"10.1073\/pnas.91.26.12559","volume":"91","author":"Y Furuta","year":"1994","unstructured":"Furuta, Y. et al. Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc Natl Acad Sci USA 91, 12559\u201312563 (1994).","journal-title":"Proc Natl Acad Sci USA"},{"key":"28242_CR57","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1146\/annurev.immunol.16.1.545","volume":"16","author":"MC Carroll","year":"1998","unstructured":"Carroll, M. C. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 16, 545\u2013568, https:\/\/doi.org\/10.1146\/annurev.immunol.16.1.545 (1998).","journal-title":"Annu Rev Immunol"},{"key":"28242_CR58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/978-1-4614-3461-0_8","volume":"750","author":"H Bouhlal","year":"2012","unstructured":"Bouhlal, H. & Kaveri, S. Multi-faceted role of naturally occurring autoantibodies in fighting pathogens. Adv Exp Med Biol 750, 100\u2013113, https:\/\/doi.org\/10.1007\/978-1-4614-3461-0_8 (2012).","journal-title":"Adv Exp Med Biol"},{"key":"28242_CR59","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.1987.03390030051019","volume":"257","author":"W Winkelstein Jr","year":"1987","unstructured":"Winkelstein, W. Jr et al. Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men\u2019s Health Study. JAMA 257, 321\u2013325 (1987).","journal-title":"JAMA"},{"key":"28242_CR60","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1073\/pnas.97.12.6820","volume":"97","author":"AE Warrington","year":"2000","unstructured":"Warrington, A. E. et al. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci USA 97, 6820\u20136825 (2000).","journal-title":"Proc Natl Acad Sci USA"},{"key":"28242_CR61","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1073\/pnas.85.11.3995","volume":"85","author":"CA Borrebaeck","year":"1988","unstructured":"Borrebaeck, C. A., Danielsson, L. & Moller, S. A. Human monoclonal antibodies produced by primary in vitro immunization of peripheral blood lymphocytes. Proc Natl Acad Sci USA 85, 3995\u20133999 (1988).","journal-title":"Proc Natl Acad Sci USA"},{"key":"28242_CR62","first-page":"50","volume":"74","author":"L Danielsson","year":"1991","unstructured":"Danielsson, L. et al. Human monoclonal antibodies with different fine specificity for digoxin derivatives: cloning of heavy and light chain variable region sequences. Immunology 74, 50\u201354 (1991).","journal-title":"Immunology"},{"key":"28242_CR63","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0092-8674(86)90887-1","volume":"46","author":"KE Mostov","year":"1986","unstructured":"Mostov, K. E. & Deitcher, D. L. Polymeric immunoglobulin receptor expressed in MDCK cells transcytoses IgA. Cell 46, 613\u2013621 (1986).","journal-title":"Cell"},{"key":"28242_CR64","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/jmv.1890290305","volume":"29","author":"VA Sundqvist","year":"1989","unstructured":"Sundqvist, V. A. et al. Human immunodeficiency virus type 1p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. J Med Virol 29, 170\u2013175 (1989).","journal-title":"J Med Virol"},{"key":"28242_CR65","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0022-1759(00)00141-1","volume":"238","author":"C Devito","year":"2000","unstructured":"Devito, C., Levi, M., Broliden, K. & Hinkula, J. Mapping of B-cell epitopes in rabbits immunised with various gag antigens for the production of HIV-1 gag capture ELISA reagents. J Immunol Methods 238, 69\u201380 (2000).","journal-title":"J Immunol Methods"},{"key":"28242_CR66","doi-asserted-by":"publisher","first-page":"e23542","DOI":"10.1371\/journal.pone.0023542","volume":"6","author":"V Tjomsland","year":"2011","unstructured":"Tjomsland, V. et al. Complement opsonization of HIV-1 enhances the uptake by dendritic cells and involves the endocytic lectin and integrin receptor families. PLoS One 6, e23542, https:\/\/doi.org\/10.1371\/journal.pone.0023542 (2011).","journal-title":"PLoS One"},{"key":"28242_CR67","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1002\/eji.201243257","volume":"43","author":"V Tjomsland","year":"2013","unstructured":"Tjomsland, V. et al. Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions. Eur J Immunol 43, 2361\u20132372, https:\/\/doi.org\/10.1002\/eji.201243257 (2013).","journal-title":"Eur J Immunol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28242-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T12:22:05Z","timestamp":1693743725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28242-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["28242"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-28242-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,5]]},"assertion":[{"value":"2 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10180"}}